SC

Sahil Chopra

Principal, Investments @ Vertex Ventures HC

San Francisco, California

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $200,000.00
  • Target Investment:

    $150,000.00

Work Experience

  • Principal

    2024

  • Vice President of Investments

    2023

  • Senior Associate

    2021

  • Investment Associate

    2019

    Vertex Ventures HC (www.vertexventureshc.com) is part of a global venture fund network under Vertex Venture Holdings, a fund anchored by Temasek Holdings, with offices in Silicon Valley, Boston, and Singapore. Vertex Ventures HC invests globally in various sectors of the healthcare industry, including biotech, biopharmaceuticals, medical devices and digital health with ~$600M under management.

  • Board Observer

    2022

2020 - 2021

  • Board Observer

    2020 - 2021

2018 - 2019

  • Venture fellow

    2018 - 2019

  • Graduate Student Researcher

    2012 - 2019

    Thesis focused on the stress sensors in the innate-immune cells of the body. Principal investigators- Dr. Laurie Glimcher (Former Dean of Weill Cornell Medicine and Current President at Dana-Farber Cancer Institute, Harvard University) and Dr. Juan Cubillos Ruiz, Cornell University - Published a first author paper in Science - Published as a co-author in Nature and Cell - Over 400 citations

2018 - 2018

  • Pro Bono Consultant

    2018 - 2018

    -Provided with a Landscape analysis -Developed a financial model to predict growth of the organization

2015 - 2017

  • Analyst

    2015 - 2017

    Provided scientific and market due diligence, business development solutions to clients that include early stage life science investors, healthcare product based companies, healthcare startups

  • General Secretary

    2010 - 2012

    -organize various technical workshops and seminars given by experts

  • Research Associate

    2011 - 2012

    -Cloning, expression, purification, characterization and computational structural analysis of heme oxygenase enzyme for drug development Principal Investigator- Dr. Suman Kundu

  • Intern

    2010 - 2010

    Identification of auto-antibodies for the differentiation of colonic Crohn’s disease from intestinal tuberculosis Principal Investigator- Dr. A. Srinivasan